FORT LAUDERDALE, Fla. — A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results